Abstract:Purpose: To compare an intensity-modulated radiotherapy (IMRT) planning approach for prostate pelvic RT with a conformal RT (CRT) approach taking into account the influence of organ-at-risk (OAR) motion. Methods and Materials: A total of 20 male patients, each with one planning computed tomography scan and five to eight treatment computed tomography scans, were used for simulation of IMRT and CRT for delivery of a prescribed dose of 50 Gy to the prostate, seminal vesicles, and pelvic lymph nodes. Planning was … Show more
“…In a comparable study by Hysing et al on prostate cancer where the target also included the regional lymph nodes, the gEUD using IMRT was 40 Gy and 46 Gy for the bowel and rectum, respectively [13]. The difference in gEUD between our study and the study by Hysing et al reflects the different volumes of normal tissue included in the PTV for prostate and bladder RT, respectively.…”
Section: Discussioncontrasting
confidence: 43%
“…However, it is well known that the ORs, and especially the bowel will change position between treatment fractions [26]. In the study by Hysing et al, the IMRT sparing of the bowel and rectum persisted when the intra-fractional movements were analyzed on repeated CT scans [13]. Because of limited accuracy and definition of the targets and ORs, comparison with other studies is difficult, and the correlation between gEUD and clinical outcome may be problematic.…”
Section: Discussionmentioning
confidence: 99%
“…Bowel gEUDs were also calculated for CRT plans with a prescribed dose to the PTV1 of 60 Gy and 64 Gy, respectively. For the bowel, we followed the method by Hysing et al, extending the Niemierko EUD equation by introducing an absolute reference volume, Vref, and by replacing the volume fraction with the absolute volume at the i th differential DVH dose bin [12,13].…”
Section: Analysis Of Dose-volume Histogramsmentioning
(2009) The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy, Acta Oncologica, 48:2, 238-244,
“…In a comparable study by Hysing et al on prostate cancer where the target also included the regional lymph nodes, the gEUD using IMRT was 40 Gy and 46 Gy for the bowel and rectum, respectively [13]. The difference in gEUD between our study and the study by Hysing et al reflects the different volumes of normal tissue included in the PTV for prostate and bladder RT, respectively.…”
Section: Discussioncontrasting
confidence: 43%
“…However, it is well known that the ORs, and especially the bowel will change position between treatment fractions [26]. In the study by Hysing et al, the IMRT sparing of the bowel and rectum persisted when the intra-fractional movements were analyzed on repeated CT scans [13]. Because of limited accuracy and definition of the targets and ORs, comparison with other studies is difficult, and the correlation between gEUD and clinical outcome may be problematic.…”
Section: Discussionmentioning
confidence: 99%
“…Bowel gEUDs were also calculated for CRT plans with a prescribed dose to the PTV1 of 60 Gy and 64 Gy, respectively. For the bowel, we followed the method by Hysing et al, extending the Niemierko EUD equation by introducing an absolute reference volume, Vref, and by replacing the volume fraction with the absolute volume at the i th differential DVH dose bin [12,13].…”
Section: Analysis Of Dose-volume Histogramsmentioning
(2009) The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy, Acta Oncologica, 48:2, 238-244,
“…Recently it has been pointed out, that over the past decade intensity-modulated radiation therapy (IMRT) has shown its superiority to three-dimensional conformal radiotherapy (3DCRT) in the treatment of prostate cancer, producing more conformal dose distributions for the target volume with minimal longterm toxicities in the organs at risk (OAR) [7,12,15]. Thereby image guidance is recommended to reduce errors of patient setup and internal motion of the prostate [12,19,24,25].Different algorithms for the optimisation have been described.…”
Background and Purpose: Intensity-modulated radiation therapy (IMRT) has shown its superiority to 3D conformal radiotherapy in the treatment of prostate cancer. Different optimisation algorithms are available: algorithms which first optimise the fluence followed by a sequencing (IM) and algorithms which involve the machine parameters directly in the optimisation process (DSS). The aim of this treatment planning study is to compare both of them regarding dose distribution and treatment time.Patients, Material and Methods: Ten consecutive patients with localized prostate cancer were enrolled for this planning study. The planning target volume (PTV) and the rectum volume, urinary bladder and femoral heads as organs at risk (OAR) were delineated. Average doses, the target dose homogeneity H, D 5 , D 95 , monitor units per fraction and the number of segments were evaluated.
Results:While there is only a small difference in the mean doses at rectum and bladder, there is a significant advantage for the target dose homogeneity in the DSS-optimised plans compared to the IMoptimised ones. Differences in the monitor units (nearly 10% less for DSS) and the number of segments are also statistically significant and reduce the treatment time.
Conclusion:Particularly with regard to the tumor control probability the better homogeneity of the DSS-optimised plans is more profitable. The shorter treatment time is an improvement regarding intrafractional organ motion. The DSS-optimiser results in a higher target dose homogeneity and, simultaneously, in a lower number of monitor units. Therefore it should be preferred for IMRT of prostate cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.